Cheryl Mendoza, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 9470 Annapolis Rd, Suite 416, Lanham, MD 20706 Phone: 301-577-4333 Fax: 301-577-5180 |
Magnolia Gardens Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6710 Mallery Dr, Lanham, MD 20706 Phone: 301-552-2000 |
Ms. Keisha Sims, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8116 Good Luck Rd, Lanham, MD 20706 Phone: 301-552-4282 |
Rakia Floyd, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9470 Lanham Road, Lanham, MD 20772 Phone: 412-652-8574 |
Angelica Prieto Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4200 Parliament Pl Ste 550, Lanham, MD 20706 Phone: 240-245-4370 |
Jaira Billups Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4451 Parliament Pl Ste A, Lanham, MD 20706 Phone: 301-577-4333 |
Irene Quintella Devon Aaron, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4200 Parliament Pl Ste 550, Lanham, MD 20706 Phone: 240-245-4370 |
News Archive
In the decade since the Human Genome Project produced the first map of DNA sequences in the human genome, scientists throughout the world have combed through genome data to identify genes and gene variants that cause human disease.
Move over, salamanders, we humans can also regrow some of our body tissues. At least, this is what a new study published on October 9, 2019, in the journal Science Advances, reports. Using a mechanism quite similar to that by which amphibians like salamanders, and some zebrafish, grow back lost body parts, human joint cartilage can also regenerate itself.
​Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study published today in Blood, the journal of the American Society of Hematology.
› Verified 9 days ago